Psychotic Disorders

Psychotic disorders, including schizophrenia, are characterized by delusions, hallucinations, and disorganized thinking. The Journal of Clinical Psychiatry offers comprehensive insights into these disorders, from their neurobiological underpinnings to evidence-based therapeutic strategies. Our expert editors ensure content is both actionable and holistic, aiding psychiatrists in offering comprehensive care to individuals with psychotic disorders.

Page 3

Recently published article about Psychotic Disorders

Clozapine-Related Cecal Volvulus

Clozapine-Related Cecal Volvulus

July 11, 2024

This case of clozapine-related cecal volvulus illustrates the need for a high index of suspicion for potentially life-threatening surgical emergencies in clozapine-treated patients.

Weekly Mind Reader: Why Its Time to Rethink Tobacco Use Disorder

news

Weekly Mind Reader: Why Its Time to Rethink Tobacco Use Disorder

June 14, 2024

New research suggests that it might be time to reconsider what we think we know about tobacco use disorder (TUD) in the United States.

Psychosis With Use of an Herbal Chinese Slimming Product

Psychosis With Use of an Herbal Chinese Slimming Product

June 11, 2024

A woman with no underlying mood disorder experienced psychotic symptoms after taking an herbal appetite suppressant.

Enhancing Postpartum Psychosis Care

Enhancing Postpartum Psychosis Care

May 29, 2024

The authors discuss the need for qualitative research to fill gaps in the current understanding of postpartum psychosis, as well as the barriers that make conducting this research a...

Psychosis, Inflammatory Biomarkers, and Subtypes of Childhood Trauma

Psychosis, Inflammatory Biomarkers, and Subtypes of Childhood Trauma

May 22, 2024

Dr Nasrallah discusses a recent study by Cuñat et al of the relationship between childhood trauma and inflammation, and why this work is unique and important.

Weekly Mind Reader: Clozapine Research, Esmethadone Efficacy, and Our First Reader Mailbag

news

Weekly Mind Reader: Clozapine Research, Esmethadone Efficacy, and Our First Reader Mailbag

May 16, 2024

This week we report on a bevy of clozapine research, a promising Esmethadone case study, and let our readers take it from there.

Antipsychotic Medication Continuation vs Taper and Discontinuation

Antipsychotic Medication Continuation vs Taper and Discontinuation

May 15, 2024

Dr Andrade discusses two studies that examined the outcomes of gradual, individualized antipsychotic dose reduction and discontinuation in patients with psychosis.

Study Reveals Unique Trait Among Female Psychopaths

news

Study Reveals Unique Trait Among Female Psychopaths

May 14, 2024

Researchers found that women with high psychopathy scores exhibit minimal head movement, a nonverbal cue also seen in male psychopaths.

Clozapine Use and Specific Indications

Clozapine Use and Specific Indications

April 29, 2024

Clozapine initiation is uncommon in people with psychotic disorders who have experienced events suggesting clozapine is indicated, with even lower rates in Black and Hispanic patients.

Psychotic Symptoms Following Ayahuasca Use

Psychotic Symptoms Following Ayahuasca Use

April 11, 2024

A 43-year-old woman with no psychiatric history developed schizophreniform psychotic symptoms after taking ayahuasca, which resolved after 1 week of risperidone treatment.

Valproate and Weight Gain: A New Look at an Old Problem

Valproate and Weight Gain: A New Look at an Old Problem

March 27, 2024

Dr Goldberg comments on a recent cohort study demonstrating a dose relationship with weight gain liability for valproate.

Associations of Valproate Doses With Weight Gain in Psychiatric Patients

Associations of Valproate Doses With Weight Gain in Psychiatric Patients

March 27, 2024

Valproate dose increase of 500 mg was associated with a weight change of +0.52% per month over a year. No associations were found between valproate dose and blood glucose,...

« 1 2 3 4 »